Please use this identifier to cite or link to this item:
Title: Demand for radiotherapy in Spain
Authors: Borrás, J. M.
López-Torrecilla, J.
Algara, M.
Palacios-Eito, A.
Gómez-Caamaño, A.
Olay, L.
Lara Jiménez, Pedro Carlos 
Rodríguez, A.
UNESCO Clasification: 32 Ciencias médicas
Keywords: Radiotherapy-demand
Optimal utilization
Evidence-based practice
Issue Date: 2017
Journal: Clinical and Translational Oncology 
Abstract: Aim: Assessing the demand for radiotherapy in Spain based on existing evidence to estimate the human resources and equipment needed so that every person in Spain has access to high-quality radiotherapy when they need it. Material and methods: We used data from the European Cancer Observatory on the estimated incidence of cancer in Spain in 2012, along with the evidence-based indications for radiotherapy developed by the Australian CCORE project, to obtain an optimal radiotherapy utilisation proportion (OUP) for each tumour. Results: About 50.5 % of new cancers in Spain require radiotherapy at least once over the course of the disease. Additional demand for these services comes from reradiation therapy and non-melanoma skin cancer. Approximately, 25–30 % of cancer patients with an indication for radiotherapy do not receive it due to factors that include access, patient preference, familiarity with the treatment among physicians, and especially resource shortages, all of which contribute to its underutilisation. Conclusions: Radiotherapy is underused in Spain. The increasing incidence of cancer expected over the next decade and the greater frequency of reradiations necessitate the incorporation of radiotherapy demand into need-based calculations for cancer services planning.
ISSN: 1699-048X
DOI: 10.1007/s12094-016-1525-x
Source: Clinical and Translational Oncology [ISSN 1699-048X], v. 19 (2), p. 204-210
Appears in Collections:Reseña
Show full item record


checked on Feb 18, 2024


checked on Feb 18, 2024

Page view(s)

checked on Jan 27, 2024

Google ScholarTM




Export metadata

Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.